The Antioxidant Analysis of Selected Types of Climbing Plants with Therapeutic Effect

European Pharmaceutical Journal Pub Date : 2020-05-01 DOI:10.2478/afpuc-2020-0008

M. Hrúzová, E. Mňahončáková, J. Šimková

引用次数: 0

Abstract

Abstract Climbing plants with therapeutic effects are relatively little studied group of medicinal species. In the collection of climbing species planted in 2019 in the Botanical Garden of the Slovak University of Agriculture (SUA) in Nitra, we observed the growth and potential food, horticulture and healing use. For the antioxidant analysis, 7 species from 152 plants of 13 genera and 22 species were selected. The highest antiradical activity was recorded in the species Vigna sinensis, where reached average measured values achieved up to 73.79%. However, the related species Vigna unguiculata achieved only 26% of antioxidant activity. Of the fruits, the highest activity was Momordica charantia in immature state (73%). Other fruits showed very low antiradical activity

查看原文本刊更多论文

几种有治疗作用的攀缘植物的抗氧化分析

摘要具有治疗作用的攀缘植物是研究相对较少的药用物种。在位于尼特拉的斯洛伐克农业大学植物园2019年种植的攀爬物种中，我们观察了它们的生长和潜在的食物、园艺和治疗用途。从13属22种152种植物中筛选出7种进行抗氧化分析。抗自由基活性最高的是中华Vigna sinensis，其达到的平均测量值高达73.79%。然而，与之相关的有蹄黑木耳仅达到26%的抗氧化活性。在果实中，未成熟状态的苦瓜活性最高（73%）。其他水果的抗自由基活性很低

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Pharmaceutical Journal Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)

CiteScore

0.60

自引率

0.00%

发文量

期刊介绍： European Pharmaceutical Journal publishes only original articles not previously published and articles that are not being considered or have not been submitted for publication elsewhere. If parts of the results have been published as conference abstract or elsewhere, it should be stated in references. The ethical standards of the Helsinki-Tokio Declaration should be kept. This should be mentioned in the Methods of manuscript. Reviews are published only on request. Authors, whose submitted research work was performed with the support of a company, should indicate this in Conflict of Interest.